The TrueBeam Linear Accelerator's RapidArc technology is effective in treating diseases such as breast cancer, prostate cancer, lung, head and neck cancer. It has the ability to target the tumour ...
A new Phase I clinical trial from London Health Sciences Centre Research Institute (LHSCRI) has found high-precision ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback